The decision is also likely to cause trouble beyond the issue of patenting. In Europe, laws governing stem-cell research vary widely from country to country. The United Kingdom and Sweden, for instance, are relatively liberal and allow research on newly collected human embryonic stem cells that are still totipotent, meaning that they could develop into a human if they were transplanted into a womb. Others are more restrictive. Germany allows research only on imported human embryonic-stem-cell lines created before May 2007. Such cultured cell lines are merely pluripotent -capable of developing only into defined tissue types. And some countries, including Ireland, have yet to legislate on the issue.
Although Bot noted that pluripotent stem cells cannot be defined as embryos because "they are no longer capable of developing into a complete human being", he did say that the embryonic source of pluripotent cells "cannot be ignored".
As his opinion places such importance on the embryonic origin of the cell linesirrespective of how long ago they were established -some think that the ruling is likely to encourage vacillating countries to introduce restrictive laws or complete bans on the research. Hans Schöler, a stem-cell researcher and director of the Max Planck Institute for Molecular Biomedicine in Münster, Germany, says that such countries are "quite obviously going to refer to a legal opinion at the European level for guidance". ■
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Work with human embryonic stem cells is 'contrary to ethics'.
'Stop patents on life', protest Greenpeace activists.
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